|

Multiple Sclerosis Clinical Trials in Denver, CO

16 recruiting studies within 50 miles

Phase
Trial Phase Dist.
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)—<1 mi
A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)Phase 1<1 mi
TSC Biosample Repository and Natural History Database—<1 mi
A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101—<1 mi
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)Phase 38 mi
An Open-label Study of AZD0120 in Adults With Multiple SclerosisPhase 18 mi
Study to Investigate Vagus Nerve Stimulation Paired With Motor Task for Remyelination and Functional RecoveryN/A8 mi
Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention StudyPhase 28 mi
Care in Multiple Sclerosis (MS)—8 mi
Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate)—8 mi
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis SpasticityPhase 28 mi
Prospective Evaluation of Sequencing From antiCD-20 Therapies to OzanimodPhase 48 mi
Blood Flow Restriction And Veterans With MSN/A8 mi
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical IllnessesPhase 28 mi
Home Based Infusions for OcrelizumabPhase 413 mi
Reducing Fatigue in People With Multiple Sclerosis by Treatment With TENSN/A24 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.